Karmanos Cancer Institute at McLaren Clarkston
Karmanos Cancer Institute at McLaren Clarkston
Clarkston, Michigan, United States6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-08-26 | NCT07227831 | |
| Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer | Metastatic Pancreatic Adenocarcinoma | Recruiting | Phase 2 | 2026-08-10 | NCT06576115 | |
| Ask Questions About Clinical Trials | cardiovascular disorder, heart disorder, neoplasm, nervous system disorder | Recruiting | Not applicable | 2026-08-06 | NCT07343297 | |
| Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies | Advanced Solid Tumor | Recruiting | Phase 1 | 2026-07-24 | NCT07098299 | |
| A Study of the TheraBionic P1 Device in Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-04-21 | NCT07218432 | |
| Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer | Metastatic Colorectal Adenocarcinoma | Recruiting | Phase 2 | 2025-11-10 | NCT07130903 |